Advances in Myelofibrosis Treatment

Stephen Oh, MD, PhD, explains the different types of myelofibrosis and describes the signs and symptoms.

An expert hematologist discusses important molecular targets in myelofibrosis, and when to consider transplant.

Stephen Oh, MD, PhD, gives a comprehensive review of the available treatment options for myelofibrosis.

An overview of momelotinib, which was recently submitted for FDA approval, and how myelofibrosis treatments affect quality of life.

Stephen Oh, MD, PhD, describes the factors that influence treatment selection in myelofibrosis, and then reviews sequencing strategies.

Expert hematologist, Stephen Oh, MD, PhD, talks about unmet needs and promising new therapies in myelofibrosis.